Apolipoprotein A (APOA) (N-Term) Peptide
APOA
适用: 人
宿主: 合成
BP, WB
-
- 抗原 See all LPA (APOA) products
- LPA (APOA) (Apolipoprotein A (APOA))
- 蛋白结构域
- N-Term
- 宿主
- 人
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB)
- 序列
- VPDPSTEASS EEAPTEQSPG VQDCYHGDGQ SYRGSFSTTV TGRTCQSWSS
- 产品特性
- This is a synthetic peptide designed for use in combination with anti-LPA Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- 纯化方法
- Purified
-
-
- 应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 浓度
- 1 mg/mL
- 缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
- 注意事项
- Avoid repeated freeze-thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- 抗原
- LPA (APOA) (Apolipoprotein A (APOA))
- 别名
- AK38 Peptide, APOA Peptide, LP Peptide, Apo(a) Peptide, Lp(a) Peptide, lipoprotein(a) Peptide, LPA Peptide
- 背景
-
LPA is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the protein contains 2-43 copies of kringle-type domains.
Alias Symbols: LP, AK38, APOA, LPA
Protein Interaction Partner: APOH,CANX,CELA1,ELANE,FBLN5,FGB,FN1,LRP2,MMP12,CANX,FGB,FN1,LRP2
Protein Size: 1169 - 分子量
- 120 kDa
- 基因ID
- 4018
- NCBI登录号
- NM_005577
- UniProt
- P08519
-
You are here:
